20 June 2021 - 08:00-12:00

1: CNS infections causing refractory SE
Raimund Helbok, Innsbruck, Austria

2: Refractory SE of autoimmune etiology
Marianna Spatola, Barcelona, Spain

3: Refractory SE in genetic disorders
Nicolas Gaspard, Brussels, Belgium

1: Precision medicine in stroke – Current applications
Svetlana Lorenzano, Rome, Italy

2: Future applications
Ana Catarina Fonseca, Lisbon, Portugal

3: Precision medicine or personalized medicine?
Louis Caplan, Boston, USA

1: Dynamic changes in awareness for cognitive decline and EEG: affordable markers of preclinical AD
Stéphane Epelbaum, Paris, France

2: Plasma biomarkers in dementia: past, present and future
Femke Bouwman, Amsterdam, Netherlands

3: Genetics of the dementias – from autosomal dominant disease to pre-symptomatic screening
Jonathan Schott, London, United Kingdom

.

1: Experimental Therapies for Huntington's Disease 
Anne Rosser, London, United Kingdom

2: Experimental Therapies for Rare Movement Disorders – MSA
Wassilios Meissner, Bordeaux, France

3: Experimental therapies for progressive supranuclear palsy 
Gunter Hoeglinger, Hannover, Germany

1: Genetics: What are the “true” genetic biomarkers in neurological disorders
Nicholas Wood, London, United Kingdom

2: Body fluid markers: recent developments
Bruno Giometto, Trento, Italy

3: Neuroimaging: Impact on treatment decisions and disease monitoring
Marion Smits, Rotterdam, The Netherlands

1: Friends: ICIs as possible treatment for infectious diseases of the CNS
Guillaume Martin-Blondel, Toulouse, France

2: Friends: ICIs as potential treatment in Neuro-Oncology
Stefan Oberndorfer, St. Pölten, Austria

3: Foes: Neurological toxicities related to ICIs
Alberto Vogrig, Lyon, France

1: Anti-MAG antibodies
Luis Querol, Barcelona, Spain

2: Anti-ganglioside antibodies
Hugh Willison, Glasgow, Scotland, United Kingdom

3: Anti-paranodal proteins antibodies
Claudia Sommer, Würzburg, Germany

1: Peripheral nerves. Conventional sensory nerve conduction studies.
Joao Leote, Lisbon, Portugal

2: Peripheral nerves. Near nerve recordings
Hatice Tankisi, Aarhus, Denmark

3: System pathways. Somatosensory evoked potentials.
Letizia Leocani, Rome, Italy

4: Sensorimotor integration: Reflex responses.
Josep Valls-Sole, Barcelona, Spain

1: Viral encephalitis
Pille Taba, Tartu, Estonia

2: Bacterial meningitis
Mathias Klein, Munich, Germany

3: The spinal cord
Bettina Pfausler, Innsbruck, Austria

1. Establishing criteria for prioritization of topics for EAN Clinical practice guidelines
Katina Aleksovska, Skopje, Macedonia

2. EAN guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias (TAC)
Rigmor Hojland Jensen, Glostrup, Denmark

3. EAN-PNS Guideline on Guillain Barré Syndrome (GBS)
Pieter van Doorn, Rotterdam, The Netherlands

4. EAN-PNS Guideline on diagnosis and management of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
Peter van den Bergh, Brussels, Belgium

1: Moritz Romberg Lecture - Romberg and his famous test - what more do we know 170 years later
Gábor Halmágyi, Sydney, Australia

2: The Brain Prize Lecture
Huda Zoghbi, Houston, USA

3: Charles Edouard Brown-Sequard  - The core/penumbra model: implications for acute stroke treatment and patient selection in 2021
Jean-Claude Baron, Paris, France

4: Camillo Golgi Lecture - History of prion science
Adriano Aguzzi, Zurich, Switzerland